Näytä suppeat kuvailutiedot

Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients

Porela Pekka; Jaakkola Samuli; Mattila Kalle; Kesti Henri; Lintu Mikko; Mäkinen Henna

dc.contributor.authorPorela Pekka
dc.contributor.authorJaakkola Samuli
dc.contributor.authorMattila Kalle
dc.contributor.authorKesti Henri
dc.contributor.authorLintu Mikko
dc.contributor.authorMäkinen Henna
dc.date.accessioned2022-10-27T12:08:44Z
dc.date.available2022-10-27T12:08:44Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/156582
dc.description.abstractIn recent years, guidelines for the management of acute coronary syndromes (ACS) have placed more emphasis on identifying patients at high bleeding risk (HBR). We set out to investigate the prevalence of HBR patients according to the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in hospitalized patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). Consecutive patients were retrospectively enrolled between January and June 2019 from the emergency department (ED) of a tertiary hospital. The discharge diagnosis and baseline data were manually collected using electronic patient records and database searches. Patients with non-cardiac diagnoses were excluded. Overall, 212 patients were included in the study. A total of 146 (68.9%) patients were diagnosed with NSTEMI (Type 1), 47 (22.2%) with unstable angina pectoris (UAP) and 19 (9.0%) with "other." HBR was detected in 47.6% (n = 101) of all patients. Common criteria for HBR among ACS patients were age (40.4%), chronic kidney disease (33.7%), and the use of oral anticoagulation medicines (20.2%). In conclusion, nearly half of the patients hospitalized for ACS fulfilled HBR criteria. According to contemporary guidelines, the management of HBR patients differs from that of non-HBR patients, and thus, a more comprehensive screening for HBR may be considered in clinical practice.
dc.language.isoen
dc.publisherMDPI
dc.titlePrevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
dc.identifier.urlhttps://www.mdpi.com/2077-0383/11/5/1324
dc.identifier.urnURN:NBN:fi-fe2022081153779
dc.relation.volume11
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organizationfi=kliinisen laitoksen yhteiset|en=Department of Clinical Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organization-code2607300
dc.contributor.organization-code2607318
dc.converis.publication-id175017257
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/175017257
dc.identifier.jour-issn2077-0383
dc.okm.affiliatedauthorJaakkola, Samuli
dc.okm.affiliatedauthorLintu, Mikko
dc.okm.affiliatedauthorPorela, Pekka
dc.okm.affiliatedauthorMattila, Kalle
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorKesti, Henri
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumber1324
dc.relation.doi10.3390/jcm11051324
dc.relation.ispartofjournalJournal of Clinical Medicine
dc.relation.issue5
dc.year.issued2022


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot